Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Introduction: The FreeStyle Libre is a flash glucose monitoring (FSL-FGM) system. Compared with finger-prick based self-monitoring of blood glucose, FSL-FGM may provide benefits in terms of improved glycemic control and decreased disease burden. Methods: Prospective nationwide registry. Participants with diabetes mellitus (DM) used the FSL-FGM system for a period of 12 months. End points included changes in HbA1c, hypoglycemia, health-related quality of life (12-Item Short Form Health Survey v2 (SF-12 v2) and 3-level version of EuroQol 5D (EQ-5D-3L)), a specifically developed patient-reported outcome measures (PROMs) questionnaire, diabetes-related hospital admission rate and work absenteeism. Measurements were performed at baseline, and after 6 months and 12 months. Results: 1365 persons (55% male) were included. Mean age was 46 (16) years, 77% of participants had type 1 DM, 16% type 2 DM and 7% other forms. HbA1c decreased from 64 (95%CI 63 to 65) mmol/mol to 60 (95%CI 60 to 61) mmol/mol with a difference of −4 (95% CI −6 to 3) mmol/mol. Persons with a baseline HbA1c >70 mmol/mol had the most profound HbA1c decrease: −9 (95% CI −12 to to 5) mmol/mol. EQ-5D tariff (0.03 (95%CI 0.01 to 0.05)), EQ-VAS (4.4 (95%CI 2.1 to 6.7)) and SF-12 v2 mental component score (3.3 (95%CI 2.1 to 4.4)) improved. For most, PROMs improved. Work absenteeism rate (/6 months) and diabetes-related hospital admission rate (/year) decreased significantly, from 18.5% to 7.7% and 13.7% to 2.3%, respectively. Conclusions: Real world data demonstrate that use of FSL-FGM results in improved well-being and decreased disease burden, as well as improvement of glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Benefits of CGM in this population include reductions in A1C, fewer severe hypoglycemia events in children and adults, increased TIR, as well as significant reductions in hospitalizations for severe hypoglycemia and DKA.156,162–168”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [164]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].
Lamers, L. M., Stalmeier, P. F. M., McDonnell, J., Krabbe, P. F. M., & Busschbach, J. J. V. (2005) · PubMed · Cited by 594
Fokkert, M. J., van Dijk, P. R., Edens, M. A., Abbes, S., de Jong, D., Slingerland, R. J., & Bilo, H. J. G. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000320 · Cited by 209
Self-citationThe health status of the Dutch population as assessed by the EQ-6D
Hoeymans, N., Lindert, H. V., & Westert, G. P. (2005) · Quality of Life Research · doi:10.1007/s11136-004-1214-z · Cited by 188
Tyndall, V., Stimson, R. H., Zammitt, N. N., Ritchie, S. A., McKnight, J. A., Dover, A. R., & Gibb, F. W. (2019) · Diabetologia · doi:10.1007/s00125-019-4894-1 · Cited by 165 · cited 1×
“This finding, based on self-reported data, is slightly in contrast with the findings in the study of Tyndall et al , 11 where hospital admission rates show a tendency to increase.”
Allergic contact dermatitis caused by medical devices for diabetes patients: A review
Herman, A., de Montjoye, L., Tromme, I., Goossens, A., & Baeck, M. (2018) · Contact Dermatitis · doi:10.1111/cod.13120 · Cited by 95
Hagell, P., Westergren, A., & Årestedt, K. (2017) · Research in Nursing & Health · doi:10.1002/nur.21806 · Cited by 94
Kröger, J., Fasching, P., & Hanaire, H. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00741-9 · Cited by 90
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Choudhary, P., Kolassa, R., Keuthage, W., Kroeger, J., Thivolet, C., Evans, M., Ré, R., de Portu, S., Vorrink, L., Shin, J., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00212-1 · Cited by 204
Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 133
Javaid, A., Zghyer, F., Kim, C., Spaulding, E. M., Isakadze, N., Ding, J., Kargilis, D., Gao, Y., Rahman, F., Brown, D. E., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100379 · Cited by 134
Metadata
- Authors
- Fokkert, M., van Dijk, P., Edens, M., Barents, E., Mollema, J., Slingerland, R., Gans, R., & Bilo, H.
- Affiliations
- Isala (NL)
- Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
- Dutch Diabetes Association, Leusden, The Netherlands
- University of Groningen (NL)
- Venue
- BMJ Open Diabetes Research & Care
- Publisher
- BMJ
- Published
- 2019-12
- Volume
- 7
- Issue
- 1
- Pages
- e000809
- ISSN
- 2052-4897 (ISSN-L)
- PMC
- PMC6904165
- OpenAlex
- W2995199934
- Cited by
- 163
- References
- 14
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 25 · 2023: 24 · 2022: 32 · 2021: 45 · 2020: 9 · 2019: 1
- FWCI
- 17.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open Diabetes Research & Care (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- flash glucose monitoring, FreeStyle Libre, type 1 diabetes, type 2 diabetes, glycemic control, HbA1c, hypoglycemia, health-related quality of life, patient-reported outcomes, disease burden, hospitalization, absenteeism, real-world evidence
- MeSH terms
- Patient Reported Outcome Measures, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Male, Middle Aged, Prognosis, Prospective Studies, Quality of Life, Blood Glucose Self-Monitoring, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). https://app.cochat.ai/papers/10.1136/bmjdrc-2019-000809
- The paper
- Fokkert, M., van Dijk, P., Edens, M., Barents, E., Mollema, J., Slingerland, R., Gans, R., & Bilo, H. (2019). Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2019-000809
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
